Nina Shah

ORCID: 0000-0002-1971-8173

Also affiliated with The University of Texas MD Anderson Cancer Center, University of California, San Francisco, Kaiser Permanente Oakland Medical Center, ImageCat (United States), AstraZeneca (Japan), University of San Francisco

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma”.

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma

Nature Communications(2020)10.1038/s41467-020-15521-4

N/A

1.8DataRank · unranked

47 citations

Ian Ferguson, Alexis M. Thornton, Prabhakar Bastola, Christine Lam, Yu-Hsiu T. Lin +14 more

Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.022

N/A

0.464DataRank · unranked

21 citations

Shaji Kumar, Raphael Fraser, Noel Estrada‐Merly, Sergio Giralt, Vaibhav Agrawal +22 more

Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8506

N/A

0DataRank · unranked

102 citations

Marcelo C. Pasquini, Edward A. Stadtmauer, Raphael Fraser, Mingwei Fei, Steven M. Devine +14 more

Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies

Circulation Research(2021)10.1161/circresaha.120.315894

N/A

0DataRank · unranked

129 citations

Olalekan O. Oluwole, Douglas B. Johnson, Nina Shah, Joe‐Elie Salem, Katy K. Tsai +2 more

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.027

N/A

0DataRank · unranked

3 citations

Nizar J. Bahlis, P. Leif Bergsagel, Manisha Bhutani, Niccolò Bolli, Carrie Brownstein +18 more

Improved outcomes with maintenance therapy after salvage autologous hematopoietic cell transplantation (AHCT) in multiple myeloma: A CIBMTR study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8022

N/A

0DataRank · unranked

1 citations

Raphael Fraser, Noel Estrada‐Merly, Moshe Yeshurun, Uri Rozovski, Liat Shargian +5 more

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia(2021)10.1038/s41375-021-01233-1

N/A

0DataRank · unranked

1 citations

Sagar S. Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Dávila +42 more

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance

Nature Communications(2022)10.1038/s41467-022-31810-6

N/A

0DataRank · unranked

130 citations

Bonell Patiño-Escobar, Sami T. Tuomivaara, Yu-Hsiu T. Lin, Matthew A. Nix, Kevin Leung +24 more

Dichloroacetate improves mitochondrial function, physiology, and morphology in FBXL4 disease models

JCI Insight(2022)10.1172/jci.insight.156346

N/A

0DataRank · unranked

14 citations

Eiko Nakamaru‐Ogiso, Neal D. Mathew, Elizabeth T. Herman, Nina Shah, Suraiya Haroon +4 more

A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation

Bone Marrow Transplantation(2022)10.1038/s41409-022-01705-7

N/A

0DataRank · unranked

10 citations

Peter F. Thall, Junsheng Ma, Benigno C. Valdez, Roland L. Bassett, Julianne Chen +20 more

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.019

N/A

0DataRank · unranked

1 citations

Fotis Asimakopoulos, Abdel Kareem Azab, Giada Bianchi, Manisha Bhutani, Leslie Crews +18 more

Impact of second primary malignancy post-autologous hematopoietic stem cell transplantation on outcomes of multiple myeloma: A CIBMTR analysis.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8057

N/A

0DataRank · unranked

0 citations

Anita D’Souza, Noel Estrada‐Merly, Raphael Fraser, Gemlyn George, Lohith Gowda +7 more

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

Blood Advances(2023)10.1182/bloodadvances.2022009138

N/A

0DataRank · unranked

36 citations

Mithun Vinod Shah, Anita D’Souza, Noel Estrada‐Merly, Lohith Gowda, Gemlyn George +37 more

Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study

Haematologica(2023)10.3324/haematol.2022.282269

N/A

0DataRank · unranked

5 citations

Mei-Jei Zhang, Linda J. Burns, Xiaoying Tang, Christa L. Meyer, Lih‐Wen Mau +18 more

CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy

Blood Advances(2024)10.1182/bloodadvances.2023012416

N/A

0DataRank · unranked

44 citations

Zenghua Fan, Kaichun Wu, Elizabeth McCarthy, Axel Hyrenius‐Wittsten, Alec Starzinski +14 more

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more